Studies in both mice and humans suggest that the anti-or pro-inflammatory nature of HDL may be a more sensitive predictor of risk for CHD events. In this paper, we report the identification and characterization of two proteins (m/z 14.9k and 15.6k) that are most dramatically associated with HDL in mouse models of atherosclerosis. Mass spectral analyses of pro-inflammatory HDL identified the two peaks to be hemoglobin (Hb) α and β chains, respectively, with no apparent posttranslational modification. Biochemical analysis confirmed the differential association of Hb with HDL from hyperilipidemic mice. We further show that HDL-associated Hb is predominantly in the oxyhemoglobin (oxyHb) form with distinct physical and chemical properties. Furthermore, oxyHb containing pro-inflammatory HDL potently consumed nitric oxide (NO) and contracted arterial vessels ex vivo. Moreover, Hb was also found differentially associated with HDL from CHD patients compared to healthy controls. Our data suggest that Hb contributes to the proinflammatory nature of HDL in mouse models of atherosclerosis and may serve as a novel biomarker for atherosclerosis in mice and humans.
Studies in both mice and humans suggest that the anti-or pro-inflammatory nature of HDL may be a more sensitive predictor of risk for CHD events. In this paper, we report the identification and characterization of two proteins (m/z 14.9k and 15.6k) that are most dramatically associated with HDL in mouse models of atherosclerosis. Mass spectral analyses of pro-inflammatory HDL identified the two peaks to be hemoglobin (Hb) α and β chains, respectively, with no apparent posttranslational modification. Biochemical analysis confirmed the differential association of Hb with HDL from hyperilipidemic mice. We further show that HDL-associated Hb is predominantly in the oxyhemoglobin (oxyHb) form with distinct physical and chemical properties. Furthermore, oxyHb containing pro-inflammatory HDL potently consumed nitric oxide (NO) and contracted arterial vessels ex vivo. Moreover, Hb was also found differentially associated with HDL from CHD patients compared to healthy controls. Our data suggest that Hb contributes to the proinflammatory nature of HDL in mouse models of atherosclerosis and may serve as a novel biomarker for atherosclerosis in mice and humans.
Atherosclerosis is the leading cause of morbidity and mortality in Western society. The inverse relationship between HDL cholesterol and the risk of atherosclerosis is well established. Although HDL cholesterol is an epidemiological predictor of risk for coronary heart disease (CHD) (1), a significant number of CHD events occur in patients with normal LDL and HDL cholesterol levels (1, 2) . Thus, there is a need for biomarkers with better predictive value (3) (4) (5) .
HDL exerts anti-inflammatory functions by promoting reverse cholesterol transport and preventing the oxidation of LDL (6, 7) . We have previously shown that the anti-inflammatory functions of HDL can be impaired in humans (3), rabbits (8) and mice (9) during inflammatory processes. This impaired HDL is proinflammatory in nature as characterized by i) decreased levels and activity of anti-inflammatory, anti-oxidant factors including apolipoprotein A1 (apoA-I) and paraoxonase 1 (PON1) (10) , ii) gain of pro-inflammatory proteins such as serum amyloid A (8), iii) increased lipid hydroperoxide content (11) , iv) reduced potential to efflux cholesterol (12) and v) diminished ability to prevent LDL oxidation (13) . The molecular changes and mechanisms that promote antiinflammatory HDL conversion to proinflammatory HDL are currently unknown. The knowledge of molecular profiles that distinguish pro-inflammatory HDL from anti-inflammatory HDL will not only allow the development of novel biomarkers for the early detection of atherosclerosis but also provide new strategies for therapeutic intervention of atherosclerosis.
The ProteinChip array technology coupled with surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) has been utilized to facilitate protein profiling of complex biological mixtures (14) (15) (16) (17) . In this paper, we report the identification and characterization of two SELDI protein peaks, Hb α and β chains, most dramatically associated with pro-inflammatory HDL in atherogenic/ hyperlipidemic mice. We demonstrate that the association of Hb with HDL also plays an important role in the modulation of HDL function suggesting that Hb may serve as a novel biomarker as well as a therapeutic target for atherosclerosis.
EXPERIMENTAL PROCEDURES
Animal experiments. Wild type, low density lipoprotein receptor-deficient (LDLR null) and apoE null, C57BL6/J wild-type female mice at age of 8 to 12 weeks were used in experiments comparing the three mouse models. Mice were fed one of three diets for the periods described: chow diet (Ralston Purina Mouse Chow), or atherogenic diet containing 15.8% fat, 1.25% cholesterol, and 0.5% cholate (Harlan Teklad, Madison, WI), or a western diet containing 42% fat, 0.15% cholesterol (Harlan Teklad). For short-term studies mice were fed the described diet for 7 days (D7), and for long-term studies mice were fed the described diet for 15 weeks (W15). Serum samples were isolated from overnight fasted mice, cryopreserved in 10% sucrose and freshly frozen at -80 o C until use.
Human samples. Human plasma samples were obtained from healthy donors and donors with stable CHD or CHD equivalents as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria.
Lipoprotein isolation. Pooled serum samples were fractionated by a gel permeation fast protein liquid chromatography (FPLC) system consisting of dual Pharmacia Superose 6 columns in series (Amersham, Piscataway, NJ). Serum (0.5 mL) was eluted with sterile PBS at a flow rate of 0.5 mL/min and fractionated for every 1 mL. (19) , and monocyte chemotactic activity assay (3, 7) .
SELDI ProteinChip analysis.
Sample preparation. Lipoproteins or serum samples were processed on normal phase (NP20), strong anion exchange (Q10), and weak cation exchange (CM10) ProteinChip arrays according to the manufacturer's protocols (Ciphergen Biosystems, Fremont, CA). NP20, Q10 and CM10 arrays were equilibrated with binding buffer (PBS with 0.1% Triton X-100, pH 7.0) prior to use. Diluted samples with binding buffer (serum/HDL supernatant at 1:25, lipoprotein fractions at 1:2) were freshly prepared prior to use.
SELDI ProteinChip data.
The data was analyzed with ProteinChip data analysis software version 3.2 (Ciphergen Biosystems) as described previously (20) . Sample statistics were performed on groups of profiles (anti-inflammatory HDL vs. pro-inflammatory HDL; normal serum vs. atherogenic serum). Protein differences (fold changes of relative intensity) were calculated among the various groups. A protein was considered differentially associated between two groups if, when compared with the one group, statistically significant differences in its intensity are observed (p<0.05).
Identification of proteins representing specific m/z peaks. SELDI protein peaks were identified as described previously (20, 21) . Briefly, HDL samples were loaded on SDS-PAGE followed by silver staining. The bands with molecular weights corresponding to the peaks of interest were excised and in-gel tryptic digestion was performed as described previously (22) . Extracted peptides were subjected to µLC/MS/MS as described previously (22) . The data was used to search mouse databases using Sonar ms/msTM (Genomic Solutions) and TurboSEQUESTTM (Thermo Fisher Scientific, Waltham, MA).
Electrophoresis and immunoblots.
Isoelectric focusing (IEF), Tris/HCl gels and all other reagents for electrophoresis were purchased from Bio-Rad (Hercules, CA). Serum (2 μL) or FPLC fractions (50 μL) were loaded on SDS-PAGE, IEF (pH3~10), Tris/HCl Native (4~15%) or IEFTris/HCl 2D gels. For 2D gels, each lane from IEF gels were cut and inserted into native gels. Samples were loaded on gels and transferred to nitrocellulose membrane (Amersham). The membrane was immunoblotted against Hb at 1:1000 (MP Biomedicals, Irvine, CA) or apoA-1 at 1:10,000 (Biodesign, Saco, ME). HRPconjugated secondary antibody (Amersham) was used at 1:10000 and the bands were visualized with ECL detection reagent (Amsersham).
Association of Hb with apoA-1 containing HDL.
ELISA. Individual serum samples from mice fed a normal chow diet (n=16) or an atherogenic diet (n=16) for 7 days, and apoE null female mice on a normal chow diet (n=8), and human plasma samples from healthy donors and patients (n=10 per group) were assayed for Hb in serum and apoA-1 containing HDL by direct and sandwich ELISA respectively according to manufacturer's protocols (Abcam, Cambridge, MA).
Hb in serum. Serum Hb was quantified by direct ELISA according to the manufacturer's protocol (Abcam). Primary antibodies against mouse Hb at 1:1000 (MP Biomedicals) or human Hb (Abcam) at 1:5000, followed by HRP-conjugated detection antibody at 1:5000 (Amersham) were used. HRP was probed with TMB solution (KPL, Gaithersburg, MD) and OD450 was measured. HRP-conjugated detection antibody was used as a standard to convert OD450 of each sample to the concentration of detection antibody. The change of each protein was determined by comparing each concentration with the average of Hb in mice on chow diet, which was set to 100%.
The association of Hb with apoA-1 containing HDL was determined by sandwich ELISA according to the manufacturer's protocol (Abcam). Briefly, 96-well PVC microfilter plates (BD) were precoated with 1 -5 μg/mL of goat anti-mouse apoA-1 (Biodesign) or rabbit antihuman apoA-1 (Abcam) at 4°C for overnight. Rabbit anti-mouse Hb at 1:1000 (MP Biomedicals) and HRP-conjugated donkey antirabbit IgG detection antibody at 1:5000 (GE Healthcare) were used to detect mouse Hb. HRPconjugated goat anti-human Hb (Abcam) was used for human Hb. HRP was probed with TMB solution (KPL) and OD450 was measured. HRPconjugated detection antibody was used as a standard to convert OD450 of each sample to the concentration of the detection antibody. The change of each protein was determined by comparing each concentration with the average of Hb in mice on chow diet, which was set to 100%.
Spectrophotometric determination of Hb. The concentrations of oxyHb and metHb were deconvoluted by fitting a set of pure species "basis spectra" to the measured spectra by means of linear regression as described previously (23) . The deconvolution method was verified when the consumption of oxyHb to the generation of metHb exhibited a one to one ratio while the total hemoglobin was conserved in all samples.
NO consumption assay.
NO consumption by HDL was tested with ProliNONOate as described previously (24, 25) . Briefly, ProliNONOate (Cayman Chemical), a pH-dependent NO timerelease donor, was added to a reaction chamber that contained 4 mL of PBS (pH 7.4) to initiate NO release. The generation of NO and the natural decay of NO in the presence of oxygen was monitored over time with a microchip sensor, ISO-NOPMC, connecting to a NO meter, ISO-NO Mark II (World Precision Instrument, Sarasota, FL). After NO level reached the maximum, HDL (10 μg/mL), Hb (10 μM) or PBS was added to the reaction chamber and NO decay was observed. NO consumption by HDL or Hb was evaluated by the rate of NO decay and half-life of NO. To determine whether NO consumption by oxyHb in HDL, all Hb species were converted to metHb, a less NO-reactive Hb species, with 20 μM potassium ferricyanide, K 3 Fe(CN) 6 , (Sigma, St. Louis, MO).
MS analysis of Hb derived from RBC and HDL.
HDL samples for MALDI analysis were spotted on Q10 ProteinChip arrays (Ciphergen) as described above and sinapinic acid was used as the matrix and placed on a custom adapter plate for analysis in a PE/Sciex PrOTOF 2000 MALDI time of flight mass spectrometer. Spectra acquired resulted from 250 -300 laser shots. HDL protein samples from mice (n=4) fed an atherogenic diet for 7 days were pooled and separated on an Eldex MicroPro HPLC using a Michrom PLRP-S reverse phase support with an aqueous acetonitrile (gradient 10 -50%) 0.1% trifluoroactic acid (TFA) solvent system to yield purified Hb α and β chains. Hb isolated from RBC was similarly prepared. A few µL of each collected HPLC fraction were analyzed by electrospray mass spectrometry using a ThermoFinnigan LTQ-FT tandem linear ion trap -Fourier transform ion cyclotron resonance high resolution mass spectrometer (Thermo Fisher Scientific). Mass spectra shown were the average of 50 -100 scans. After each reported mass value for the most abundant isotope peak, the mass difference (in units of 1.00235 Da) between the most abundant isotope peak and the mono-isotopic peak was denoted in italics. In order to assign the Hb α and β chain variants, a portion of each of the collected HPLC fractions was digested with trypsin and the resulting peptide mixture analyzed by liquid chromatography/ tandem mass spectrometry (LC/MS/MS Vasoreactivity studies. The effects of HDL on vasoreactivity were performed as described previously with some minor modifications (26) (27) (28) . Briefly, 2 mm long thoracic aortic rings (150 -250 μm in diameter) were prepared from 3 months old C57BL6/J female mice. The rings were mounted between two 40 μm diameter wires (one attached to an adjustable support and the other to a force transducer) in bath chambers on a small vessel wire myograph (Multi-Myograph 610M, Danish Myo Technology, Aarhus, Denmark) containing 5 mL of Krebs-bicarbonate solution (pH 7.4) at 37°C, gassed with 95% O 2 + 5% CO 2 . Tension was continuously recorded on a computer connected to PowerLab Model 4SP data acquisition system using Chart 5 software (ADI Instruments Pty. Ltd, Australia). All experiments were performed at 37°C.
After the rings were equilibrated, submaximal precontraction with phenylephrine (PE, 0.1 μM) and relaxation with acetylcholine (Ach, 10 μM) were tested for the integrity of the endothelium. Following wash and equilibration, one cycle of contraction with PE and relaxation with Ach was performed to determine the maximum relaxation by Ach. To determine the effects of HDL on the arterial relaxation, the rings were contacted with PE, incubated with HDL (10 μg/mL) for 15 min, and relaxed with Ach. The direct arterial relaxation by HDL and effects of HDL on Achmediated relaxation were determined by changes in arterial contraction before and after relaxation by Ach. After the experiments were completed, endothelial independent relaxation was evaluated with papaverine (1 nM).
Statistical analysis. All data were statistically analyzed by T-test unless specified. Significance was determined as p<0.05.
RESULTS
C57BL6/J mice fed a normal chow have antiinflammatory HDL, whereas C57BL6/J mice fed an atherogenic diet for both short term (7 days, D7) and long term (15 weeks, W15) have proinflammatory HDL (29, 30) as determined by decreased cholesterol, increased LOOH content, reduced PON1 activity, and decreased cholesterol efflux (Figure 1, A-D) . SELDI ProteinChip analysis using strong anion exchange (Q10) ProteinChip arrays identified a set of fourteen m/z peaks differentially associated with HDL from atherogenic diet fed mice (Supplemental Table 1 Figure 2A ) and HDL ( Figure 2B ) obtained from four different mouse models of atherosclerosis/hyperlipidemia. All subsequent experiments for the identification and characterization of proteins representing SELDI peaks m/z 14.9k and 15.6k were performed on serum and HDL samples obtained from D7 and W15 groups of C57BL6/J mice on an atherogenic diet.
Identification of candidate proteins at m/z 14.9k and 15.6k. To determine the identity of the proteins representing the two SELDI peaks, we first examined the pI range for the two peaks. Individual HDL samples obtained from D7 and W15 groups on chow or atherogenic diet were subjected to anion exchange (Q10) fractionation. The fractions were eluted with different pH buffers and further analyzed by SELDI-TOF-MS ( Figure 3A) . Most of the intensity representing the two peaks m/z 14.9k and 15.6k eluted with buffers at pH 7.5 or higher, except HDL from W15 on atherogenic diet (not shown). Using an online TagIdent protein database with the size determined from SELDI-TOF-MS analysis and the corresponding pI as determined by anion exchange fractionation, Hb α and β chains were identified as potential candidate proteins for the 14.9k and 15.6k respectively.
Identification of the two biomarker proteins in the
fractions at pH 7.0 and 4.0 as Hb α and β chains by tandem mass spectrometry. Based on the literature the pI for free Hb ranges between 7.0 -8.5. Interestingly, the two peaks representing m/z 14.9k and 15.6k that were associated with HDL from atherogenic mice eluted at pH 7.0 and pH 4.0 ( Figure 3A) . Western blots analysis revealed that HDL from only atherogenic mice, not mice on a normal chow, contained Hb in the fractions at pH 7.0 and 4.0 ( Figure 3B ). To further confirm the identities of the two biomarkers, the peaks corresponding m/z 14.9k and 15.6k in the anion exchange (Q10) fractions at pH 7.0 and 4.0 were separated by SDS-PAGE, extracted, digested with trypsin, and subjected to µLC/MS/MS analysis. The resulting fragments were searched against mouse protein databases (Sonar and SEQUEST) and identified as Hb α and β chains. These data suggested that Hb α and β chains represent m/z 14.9k and 15.6k that are differentially associated with HDL from atherogenic mice.
Hb associates preferentially with HDL from atherogenic/hyperlipidemic mice. To validate the presence of Hb in pro-inflammatory HDL from atherogenic mice by non-SELDI methods, we first tested serum samples from mice on the atherogenic diet on SDS-PAGE and immunoblotted for Hb. The total amount of Hb in serum samples was not significantly different between normal and atherogenic serum ( Figure  4A ). This is further confirmed by SELDI ProteinChip analysis with normal phase (NP20) arrays (data not shown). However, IEF/native 2D gels showed that unique Hb complexes at low pI were formed in atherogenic serum ( Figure 4B ). Lipoprotein fractionation followed by SDS-PAGE analysis ( Figure 5A ) and spectrophotometric analysis on Hb further confirmed the significant increases of Hb in HDL from atherogenic mice ( Figure 5B ).
Accumulation of Hb associated apoA-1 in HDL from atherogenic/hyperlipidemic mice. To determine whether Hb was physically associated with HDL, ELISA analyses were performed on serum samples. Direct ELISA once again, revealed no significant difference in serum Hb content among all groups ( Figure 5C ). However, sandwich ELISA analyses using an apoA-I capture antibody combined with Hb detection antibody identified elevated Hb levels in HDL from atherogenic mice ( Figure 5D ).
Accumulation of Hb associated apoA-1 in HDL from healthy and patient samples.
To determine whether Hb is differentially associated with HDL in humans, 10 samples each from healthy controls and patients with CHD were examined for apoA-1-associated Hb ( Figure 6 ). To determine whether cholesterol quantity affects the accumulation of Hb, each of the two groups were further divided into two groups based on cholesterol ( Figure 6A ). HDL from healthy donors whether from a low cholesterol or high cholesterol group, as expected, was protective in a cell-based monocyte chemotactic assay (3) ( Figure 6B ), whereas the two patient groups of patient samples were proinflammatory in the assay ( Figure 6B ). More interestingly, the patient samples had significantly higher levels of apoA-1-associated Hb compared to healthy samples ( Figure 6C ), independent of cholesterol levels, suggesting that Hb associates with pro-inflammatory HDL in mice and humans.
Characterization of Hb associated with HDL fractions.
To characterize the distinct physical and chemical properties of Hb associated with HDL, serum samples and HDL fractions from D7 and W15 groups on chow or atherogenic diet were subjected to native gel electrophoresis ( Figure 7A ) and iso-electric focusing (IEF) gel electrophoresis ( Figure 7B ). Native gels showed the association of Hb with high molecular weight (HMW) particles in atherogenic serum, which was exclusively associated with HDL from W15 on atherogenic diet ( Figure 7A ). IEF gels demonstrated that Hb in the atherogenic serum had a reduced pI value around 4, while normal Hb had a pI value around 8 ( Figure 7B ). The transition of the normal/free Hb (pI 8) to the modified Hb associated with HDL in atherogenic serum (pI 4) was clearly seen in samples from the D7 group. These changes were not due to changes in RBC since RBC isolated from the same groups of mice showed Hb with a normal pI ( Figure 7B ). These observations along with IEF/native 2D gels ( Figure 4B ) confirmed that Hb from atherogenic serum has multiple forms (based on pI) and associate primarily with HDL.
Hb in HDL has distinct properties but is not modified. To determine whether the distinct properties of Hb associated with HDL from atherogenic mice is due to protein modification(s), MALDI analysis was performed for Hb extracted from RBC and Q10 ProteinChip arrays spotted with HDL from the D7 group. MALDI spectra showed prominent peaks (Supplemental Figure 2) in the mass range consistent with Hb α and β chains from RBC (Table 1) . These peaks were absent in the spectra of samples derived from HDL from normal sera (Supplement Figure 1) ), and metHb (Fe 3+ ). Spectrophotometric analyses of HDL from normal and atherogenic mice revealed that the major Hb species associated with HDL from atherogenic mice is in oxyHb form ( Figure  8) , with small amounts of metHb; however, we did not detect any deoxyHb. Moreover, we further quantified the composition of HDL-bound Hb and compared it with Hb prepared from RBC and found similar proportions of oxyHb (87.3 ± 3.1% for RBC and 75.9 ± 5.2% for the atherogenic HDL) and metHb (12.7% for RBC and 24.1% for the atherogenic HDL). Interestingly, in sharp contrast to normal HDL ( Figure 9C and 9F), HDL from atherogenic mice consumed NO readily ( Figure 9D and 9F) which was prevented when the oxyHb HDL was converted to the inert metHb using potassium ferricyanide ( Figure 9E ). Furthermore, spectrophotometric analyses of HDL revealed that HDL from atherogenic mice contained higher concentrations of ONOO -( Figure 9G ). These data suggest that HDL from atherogenic mice could participate in the sequestration and oxidation of NO through the Hb-complexes associated with it.
HDL containing oxyHb causes impaired endothelium-dependent
relaxation. NO consumption by pro-inflammatory HDL suggests that Hb content, particularly oxyHb, in proinflammatory HDL may play a role in the vasomotor dysfunction. To test this hypothesis, we performed vasoreactivity experiments and analyzed vasoconstriction and vasodilation in normal mouse arteries in the presence of HDL from mice fed either a chow diet or an atherogenic diet ( Figure 10A ). HDL from atherogenic mice caused further vasoconstriction of pre-contracted arteries with 0.1 μM phenylephrine (11%) ( Figure  10B ) and impaired acetylcholine-mediated relaxation (~50%) ( Figure 10C ) indicating that both basal and stimulated release from the endothelium was impaired when compared to normal HDL, which weakly relaxed arteries (3%) and had no influence on acetylcholine-mediated vasodilation. Thus, HDL from atherogenic mice may promote vasomotor dysfunction when compared to normal/anti-inflammatory HDL presumably through sequestration of NO released from the endothelium. There was no impairment in smooth muscle ability to relax as demonstrated by the papaverine-elicited relaxation. These studies suggest that Hb-HDL complexes have the potential to impair vasomotor function in vivo.
DISCUSSION
Protein profiling is an efficient way to determine differentially expressed and/or associated proteins in complex biological mixtures, such as serum and lipoproteins, and allows rapid evaluation of biologically important functions. We have utilized SELDI-TOF-MS system to facilitate protein profiling of complex biological mixtures (14) (15) (16) (17) and previously reported the identification of biomarkers for the early detection of ovarian cancer (20, 21) . We have now utilized the discovery capabilities of SELDI technique and identified protein peaks that differentiate proinflammatory HDL from normal/antiinflammatory HDL.
Biochemical analysis of the protein profiles identified Hb α chain (14.9k) and β chain (15.6k) as two of the potential biomarkers associated with pro-inflammatory HDL in mouse models of atherosclerosis/hyperlipidemia. These identifications were confirmed by different MS techniques described above. We were initially concerned with this finding since mechanical handling and/or sample preparation could potentially result in RBC lysis and Hb release. However, subsequent careful repetitions of these experiments determined that Hb was not an artifact but rather a specific and significant marker of pro-inflammatory HDL present in atherogenic serum. First, we showed that total Hb mass was not significantly different between serum samples obtained from chow and atherogenic diet fed mice ( Figure 4A and 5C ). Second, during the conversion of normal HDL into pro-inflammatory HDL (chow vs. atherogenic diet), we did not find any modification of Hb ( Figure 7B and Table 2 ) in RBC lysates obtained from the same mice, once again suggesting that Hb association with proinflammatory HDL is a specific phenomenon under pro-inflammatory conditions. Third, the association of Hb with pro-inflammatory HDL was dependent on the extent of pro-inflammatory conditions as evident by comparing Hb in D7 and W15 lipoprotein samples ( Figure 5 and 7) . Finally, in four different models of atherosclerosis/ hyperlipidemia including apoE null mice, which have pro-inflammatory HDL on a chow diet, Hb was associated with HDL. Taken together, these results suggest that HDLassociated Hb is a biomarker of pro-inflammatory HDL.
Physiological pI for Hb has been reported to be between pI 7.0 and 8.5. We found that Hb associated with pro-inflammatory HDL has at least two Hb species with distinct pI values (Figure 3 and 7B) . After 15 weeks on the atherogenic diet all of the Hb associated with HDL demonstrated this abnormal pI. The changes in the pI of Hb after feeding the atherogenic diet may likely relate to its association with HDL, not Hb, induced by the diet since Hb associated with HDL showed no modification and its sequence was identical to the Hb from RBC (Table 2) . Although refolding of the Hb polypeptide chains in the modified HDL microenvironment may account for some of the changes it is unlikely that the drastic alterations observed in the properties are a result of subtle misfolding. To our knowledge, the different forms of Hb (oxy, met and deoxy) are not vastly different from one another in pI. However, it should be noted that HDL is a huge complex with an overall pI around 5. Therefore, one likely explanation is that the pI of Hb is not altered but rather the association, as a complex with HDL, is what makes the Hb travel at a different pI on IEF gels. Furthermore, as will be discussed below, Hb might be sequestered to HDL through a physiological scavenger pathway that involves haptoglobin.
We saw modest differences in the composition of Hb species between RBC and atherogenic HDL. It is surprising that an extracellular Hb species is kept in its ferrous form in the absence of metHb reductase, since in the presence of oxygen Hb undergoes rapid autoxidation to metHb. Thus it appears that the heme moiety in the HDL-bound Hb may be protected from autoxidation by HDL components and/or other scavenger proteins such as hemopexin discussed below. Hb associated with pro-inflammatory HDL was the pro-oxidant form, oxyHb, which consumed NO ( Figure 9 ) and contracted the aortic rings ( Figure 10 ). Recent studies demonstrated that Hb could oxidize LDL and alter the anti-atherogenic properties of HDL, including its ability to efflux cholesterol (13) . Taken together, Hb associated with proinflammatory HDL might not be only a biomarker of pro-inflammatory HDL, but also might be involved in the conversion of HDL from antinflammatory to pro-inflammatory.
Haptoglobin (Hp) and Hemopexin (Hx) are plasma proteins with the highest binding affinity for hemoglobin (Hb) (K d ≈ 1 pM) and heme (K d < 1 pM), respectively. They are expressed mainly in the liver and belong to the family of acute phase proteins, whose synthesis is induced during inflammatory processes (31, 32) . It is well established that Hb (the most abundant and functionally important protein in erythrocytes), once released from RBC, becomes highly toxic because of the oxidative properties of heme, which participates in the Fenton reaction to produce reactive oxygen species causing cell injury (33) . The toxicity of heme is increased by heme hydrophobicity, which enables it to intercalate into lipid membranes and other lipophylic compartments when not associated with proteins (34) (35) . Once in the plasma, free Hb rapidly dissociates in dimers that are bound by Hp. Metabolism of plasma Hb is considered a main function of tissue macrophages, which can take up Hb-Hp complexes through the macrophage scavenger receptor CD163 (36, 37) and internalize them for the degradation (38) . Interestingly, a very recent study identified low-density lipoprotein receptor-related protein (LRP)/CD91 (39) as the receptor responsible for scavenging hemopexinheme complexes. LRP/CD91 is expressed in several cell types including macrophages, and hepatocytes, which can internalize the heme-Hx complex through receptor-mediated endocytosis (40) . In the experiments reported here, we did not see a release of Hb from RBC but rather a conversion of existing Hb into a alternative form (not reported previously) that associates with HDL fractions. It is possible that under oxidative stress conditions, Hb-Hp-Hx complexes are formed and associated with HDL for rapid clearance from the circulation. Indeed, Hp has been reported to associate with apoA-1, the major protein component of HDL (41) (42) (43) (44) . Hp association of apoA-1 alters HDL function (45, 46) .
Hb is a known marker for injuries and diseases associated with glycemia, oxidative stress, hypertension, insulin resistance, obesity, and diabetes (47) (48) (49) . Hb is also considered to be toxic since free Hb is also a potential oxidant due to its heme (Fe) and heme-bound reactive radicals (50), which have also been shown to oxidize LDL in vivo (51) (52) (53) . Our findings show for the first time that in an oxidative stress environment Hb associates with HDL fractions in mice. Proinflammatory HDL in atherogenic serum contains lipid hydroperoxides (LOOH), lacks paraoxonase activity, activates monocytes, fails to prevent the oxidation of LDL and exhibits less cholesterol efflux (54). Here we report that Hb specifically associates with pro-inflammatory HDL in atherogenic mice. It is possible that Hb association with HDL might be involved in the conversion of HDL from anti-inflammatory to pro-inflammatory. However, further direct studies are needed before we can conclude this relationship between Hb and HDL function.
In conclusion, Hb with distinct physical and chemical properties associates with proinflammatory HDL in animal models of atherosclerosis and in human samples in preliminary experiments. If these data can be extended to large human population studies, Hb associated HDL, may serve as a novel marker of pro-inflammatory HDL.
ABBREVIATIONS
apoA1, apolipoprotein A1; apoE, apolipoprotein E; BSA, bovine serum albumin; CHD, coronary heart diseases; ELISA, enzyme-linked immunosorbent assay; Hb, Hb; HDL, Highdensity lipoprotein; LDL, low-density lipoprotein; LDLR, LDL receptor; metHb, metHb; NO, nitric oxide; oxy Hb, oxyHb; PON1, paraoxonase 1; RBC, red blood cells; SELDI-TOF-MS, surfaceenhanced laser desorption/ionization time-offlight mass spectrometry; VLDL, very lowdensity lipoprotein. A) Serum or B) HDL samples from C57BL6/J mice on atherogenic diet for 7 days (D7, n=12), 15 weeks (W15, n=12) or western diet for 10 days (WD, n=8), or LDLR null mice on western diet for 8 weeks (LDLR-/-, n=4) or 12 week old apoE null mice on normal chow (apoE-/-, n=12), were subjected to SELDI ProteinChip analysis with Q10 (pI<7) ProteinChip arrays. The two SELDI peaks of interest (m/z 14.9k and 15.6k) in serum or HDL from mice on an atherogenic diet were compared with those of serum or HDL from the corresponding control group of mice on chow diet or in the case of apoE null mice with age matched C57BL6/J mice on chow diet, and the resulting intensities were statistically analyzed. Each bar represents average fold increase with one standard deviation in each peak of m/z 14.9k (white) and 15.6k (gray). The data presented are all statistically significant with a p-value of < 0.05. A) The spectra of all samples and pure species were scanned from 380 − 700 nm. B) Spermine NONOate, a slow time-release NO donor, was added to HDL from mice fed an atherogenic diet for 7 days to observe the conversion of oxyHb to metHb. The concentrations of oxyHb and metHb were deconvoluted by fitting a set of pure species "basis spectra" to the measured spectra by means of linear regression (1) . The concentrations of Hb in C) pooled serum, D) HDL and E) post HDL (pHDL) from pooled serum (n=4 per group) of mice (n=12 per group) on a normal chow (C) or atherogenic diet (A) for 7 days (D7) were determined by spectrophotometer as described in Experimental Procedures. Each bar represents average fold with one standard deviation. p-values were calculated by T-test and (*) shows p<0.05. Figure 9 . NO consumption assay and NO content in HDL from atherogenic mice. Hb or HDL were incubated with ProliNONOate, a pH-dependent NO time-release donor, to determine the NO consumption. PBS at pH7.4 was used to start releasing NO. A) In the absence of sample, the generation of NO from the NO donor and the natural decay of NO in the presence of oxygen was monitored in electrical current (pA) over time with a microchip sensor connecting to a NO meter. After NO level reached the maximum, B) Hb purified from RBC, HDL (10 µg/mL) from mice fed a normal chow (C) or atherogenic diet (D) for 7 days was added to the reaction chamber and NO decay was observed. E) HDL from atherogenic mice was pretreated with potassium ferricyanide (20 µM) and Hb was converted to metHb before addition to the reaction chamber. F) Effect of purified Hb from RBC lysate or HDL isolated from either chow fed mice, HDL (C) or atherogenic diet, HDL (A), on half-life of NO using the NO consumption assay (n=4 per group). Each bar represents average with one standard deviation. G) The concentrations of ONOO -in HDL (n=4 per group) from pooled serum of mice (n=12 per group) on a normal chow, HDL (C) or atherogenic diet, HDL (A) for 7 days were determined by the absorbance at 302nm. Open circles and bars represent individual or average concentrations of ONOO -respectively. pvalues were calculated by T-test. Figure 10 . Effect of Hb containing HDL on vasoreactivity. A) Thoracic aorta was precontracted with phenylephrine (PE, 0.1 µM), followed by incubation with HDL (10 ug/mL) and relaxed with acetylcholine (Ach, 10 µM). HDL was isolated by FPLC from pooled serum obtained from either mice on a normal chow, HDL (C) (shown by a gray line), or atherogenic diet for 7 days, HDL (A) (shown by a black line). Upon addition of the atherogenic HDL (A), both basal NO release and acetylcholinestimulated release were impaired, compared with the normal HDL(C) addition which caused a weak relaxation to basal NO release and a strong relaxation to acetylcholine. The artery relaxation assay was repeated with HDL (10 µg/mL) from pooled samples (n=4 per group) from mice on a normal chow, HDL (C) or atherogenic diet, HDL (A). B) The vascular response to HDL and C) the effects of HDL on Ach-mediated relaxation are represented as percent changes. Each bar represents average of changes on vascular response of each group with one standard deviation. p-values were calculated by T-test. Table 1 Comparison of the theoretical mass values for mouse Hb alpha and beta chains and those observed from the electrospray mass spectra of individual chains isolated by reverse phase liquid chromatography of the HDL fraction from atherogenic mice and red blood cells from normal control mice. A) Serum or B) HDL samples from C57BL6/J mice on atherogenic diet for 7 days (D7, n=12), 15 weeks (W15, n=12) or western diet for 10 days (WD, n=8), or LDLR null mice on western diet for 8 weeks (LDLR-/-, n=4) or 12 week old apoE null mice on normal chow (apoE-/-, n=12), were subjected to SELDI ProteinChip analysis with Q10 (pI<7) ProteinChip arrays. The two SELDI peaks of interest (m/z 14.9k and 15.6k) in serum or HDL from mice on an atherogenic diet were compared with those of serum or HDL from the corresponding control group of mice on chow diet or in the case of apoE null mice with age matched C57BL6/J mice on chow diet, and the resulting intensities were statistically analyzed. Each bar represents average fold increase with one standard deviation in each peak of m/z 14.9k (white) and 15.6k (gray). The data presented are all statistically significant with a p-value of < 0.05. A) The spectra of all samples and pure species were scanned from 380 − 700 nm. B) Spermine NONOate, a slow time-release NO donor, was added to HDL from mice fed an atherogenic diet for 7 days to observe the conversion of oxyHb to metHb. The concentrations of oxyHb and metHb were deconvoluted by fitting a set of pure species "basis spectra" to the measured spectra by means of linear regression (1) . The concentrations of Hb in C) pooled serum, D) HDL and E) post HDL (pHDL) from pooled serum (n=4 per group) of mice (n=12 per group) on a normal chow (C) or atherogenic diet (A) for 7 days (D7) were determined by spectrophotometer as described in Experimental Procedures. Each bar represents average fold with one standard deviation. p-values were calculated by T-test and (*) shows p<0.05. . NO consumption assay and NO content in HDL from atherogenic mice. Hb or HDL were incubated with ProliNONOate, a pH-dependent NO time-release donor, to determine the NO consumption. PBS at pH7.4 was used to start releasing NO. A) In the absence of sample, the generation of NO from the NO donor and the natural decay of NO in the presence of oxygen was monitored in electrical current (pA) over time with a microchip sensor connecting to a NO meter. After NO level reached the maximum, B) Hb purified from RBC, HDL (10 µg/mL) from mice fed a normal chow (C) or atherogenic diet (D) for 7 days was added to the reaction chamber and NO decay was observed. E) HDL from atherogenic mice was pretreated with potassium ferricyanide (20 µM) and Hb was converted to metHb before addition to the reaction chamber. F) Effect of purified Hb from RBC lysate or HDL isolated from either chow fed mice, HDL (C) or atherogenic diet, HDL (A), on half-life of NO using the NO consumption assay (n=4 per group). Each bar represents average with one standard deviation. G) The concentrations of ONOO -in HDL (n=4 per group) from pooled serum of mice (n=12 per group) on a normal chow, HDL (C) or atherogenic diet, HDL (A) for 7 days were determined by the absorbance at 302nm. Open circles and bars represent individual or average concentrations of ONOO -respectively. pvalues were calculated by T-test. Hb as a marker of Pro-inflammatory HDL Supplemental Table 1 . Common m/z peaks associated with pro-inflammatory HDL from C57BL6/J, LDLR null, and apoE null mice.
FOOTNOTES

Supplemental
Numbers in parentheses represent protein peaks with a decrease in fold-change. WT = m/z peaks differentially associated with pro-inflammatory HDL in wild-type C57BL6/J mice, LDLR-/-= m/z peaks associated with pro-inflammatory HDL from LDLR null mice, apoE-/-= m/z peaks associated with pro-inflammatory HDL from ApoE null mice. Table 1 Common SELDI peaks differentially associated with pro-inflammatory HDL from three mouse models of atherosclerosis. Supplemental Figure 4 Supplemental Figure 5 . Isotope distributions for mouse Hb α (left hand column) and β chains (right hand column). The calculated mass value for the most abundant peak in the cluster is 14980.76 for the α chain and 15616.14 for the β chain (upper row). These values match within experimental error the values observed for Hb isolated from RBC (middle row) and for Hb isolated from HDL for the most abundant charge state (17+) Supplemental Figure 5 
